MGI PHARMA, INC.

78 articles about MGI PHARMA, INC.

• 

  Lantern, Allarity Come Together to Tackle Bladder, Prostate Cancer

  7/26/2021

  ​Lantern will reacquire the Irofulven program and evaluate its potential for advanced development to treat bladder and prostate cancers. 

• MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform

  10/17/2019

  Results from early access collaborators show high quality and reproducibility

• Eisai Company, Ltd. Completes Acquisition of MGI PHARMA, INC.

  1/29/2008

• Eisai Company, Ltd. Announces Completion of Tender Offer for MGI PHARMA, INC. Shares

  1/28/2008

• MGI PHARMA, INC. Announces Results from Study Involving the Dual Implantation of Gliadel® Wafer and Radioactive Seeds for Treatment of Recurrent Glioblastoma Multiforme

  1/18/2008

• Eisai Company, Ltd. and MGI PHARMA, INC. Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA

  1/17/2008

• MGI PHARMA, INC. Release: Notice of Correction to Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024

  1/8/2008

• MGI PHARMA, INC. and Helsinn Healthcare SA Announce sNDA for Aloxi Capsules Accepted for Review by U.S FDA

  1/3/2008

• MGI PHARMA, INC.: Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024

  12/27/2007

• Eisai Company, Ltd. Commences Cash Tender Offer for All Outstanding Shares of MGI PHARMA, INC.

  12/21/2007

• MGI PHARMA, INC. Announces Aquavan NDA Accepted for Review by U.S. FDA

  12/17/2007

• MGI PHARMA, INC.: Dacogen(R) (Decitabine) for Injection Data Presented at the American Society of Hematology 49th Annual Meeting and Exposition

  12/11/2007

• Japan's Eisai Company, Ltd. to Buy U.S. MGI PHARMA, INC. (Jobs) for $3.9 Billion

  12/10/2007

• MGI PHARMA, INC. Issues Statement

  11/29/2007

• MGI PHARMA, INC. To Present at The BMO Capital Markets 7th Annual Focus on Healthcare Conference

  11/27/2007

• MGI PHARMA, INC. To Present at the Lazard Capital Markets 4th Annual Healthcare Conference

  11/20/2007

• Company Profile for MGI PHARMA, INC.

  11/7/2007

• MGI PHARMA, INC. and Helsinn Healthcare SA Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules

  10/30/2007

• MGI PHARMA, INC.'s Aquavan® Phase 3 Bronchoscopy Data Presented At CHEST 2007

  10/23/2007

• MGI PHARMA, INC. Reports Third Quarter 2007 Financial Results

  10/18/2007